期刊文献+

新疆汉族、维吾尔族HPV16E6基因变异与子宫颈癌及宫颈病变的关系 被引量:6

The relationship of HPV16E6 mutation to cervical lesions and cervical carcinoma in Han and Uygur in Xinjiang
下载PDF
导出
摘要 目的探讨新疆地区汉族、维吾尔族宫颈癌及宫颈病变中HPV16型E6基因变异分布及频率,比较两个民族之间的差异。方法对140例HPV16阳性标本,设计E6基因特异性引物,通过PCR扩增HPV16E6全长基因,PCR产物直接测序,进行序列分析并与德国标准株对比,筛选突变位点。结果 123例汉族、维吾尔族妇女宫颈癌及宫颈病变标本中均存在HPV16E6变异株,其中突变率分别为:47.37%(27/57)和50%(33/66),E6突变位点主要是L83V、D25E、D64E、I73V、H78Y、D113E,其中L83V变异株在两个民族突变中占的比例均最高,汉族L83V突变频率为29.82%(17/57)显著低于维吾尔族的40.90%(27/66)(P<0.05)。而汉族D25E突变频率为19.30%(11/57)显著高于维吾尔族的7.58%(5/66)(P<0.05),D64E变异株在维族突变株中占的比例为6.1%,而汉族标本中未检出。结论两个民族HPV16 E6基因变异发生的位置和变异发生的频率存在差异,维吾尔族人群中HPV16E6基因D64E变异株可能与该地区维吾尔族宫颈癌高发存在一定的关系。 Objective To investigate distribution of HPV16E6 mutation and whether there are differences in Han, Uygur cervical cancer( CC) and precancerous lesions. the relationship between the mutation and high incidence of CC in Han and Uygur women. Methods 140 precancerous lesions samples and cervical carcinoma patients with HPV16 genotypes was chosen and HPV16E6 gene was amplified by polymerase chain reaction(PCR). The PCR fragments were sequenced and analyzed. Results There was mutations in 123 cases,the distribution in Han and Uygur were 47. 37%( 27 /57) and 50%( 33 /66) respectively. They were positive for mutations D25E, D64E, I73V, H78Y,D113E,L83V,the hot mutation was L83V with rates was 29. 82%(17 /57)in Han and 40. 90%(27 /66) in Uygur,Rates was D25E 19. 30%(11 /57)in Han and 7. 58%(5 /66)in Uygur. Rates of D64E 6. 1% was only found in Uygur. Conclusions There was difference between HPV16E6 gene mutation sites and rates in two na-tions. Our research suggested that the distribution of D64E in Uygur might be associated with higher incidence of CC in this population.
出处 《基础医学与临床》 CSCD 北大核心 2014年第1期11-15,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(81160317) 自治区人民医院院内科研基金(20080110)
关键词 汉族 维吾尔族 宫颈癌及宫颈病变 人乳头瘤病毒 E6基因 Han Uighur cervical cancer and lesions human papillomavirus E6 gene
  • 相关文献

参考文献12

二级参考文献47

  • 1马正海,张富春,梅新娣,马彩玲,刘开江.新疆维吾尔族妇女宫颈癌组织中HPV16型E6基因突变分析[J].癌症,2004,23(9):1016-1020. 被引量:17
  • 2骆成玉,祝学光.肿瘤微转移检测研究的现状和存在的问题[J].基础医学与临床,2004,24(5):578-581. 被引量:4
  • 3李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 4古扎丽努尔.阿不力孜,程静新,米克热木,古兰丹,李华,米合日尼沙,米日古丽,米日古丽.艾乃土,路玲.新疆维吾尔族妇女宫颈癌的HPV谱研究[J].肿瘤,2007,27(5):379-382. 被引量:48
  • 5Matsumoto K, Yoshikawa H, Nakagawa S, et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population [J]. Cancer Lett,2000,156:159- 165.
  • 6Londesborough P, Ho L, Terry G, et al. Human papillomavirus genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities [J]. Int J Cancer, 1996, 69:364- 368.
  • 7Zehbe I, Wilander E, Delius H, et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype [J]. Cancer Res, 1998, 58:829- 833.
  • 8Zehbe I, Voglino G, Wilander E, et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development [J]. Cancer Res, 2001, 61:608- 611.
  • 9Zehbe I, Voglino G, Delius H, et al. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms [J]. Lancet, 1998, 352:1441- 1442.
  • 10Zehbe I, Tachezy R, Mytilineos J. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes [J]. Int J Cancer, 2001, 94:711- 716.

共引文献34

同被引文献36

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部